Síndrome de predisposição hereditária ao câncer de mama e ovário: aspectos clínicos, epidemiológicos e genéticos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Hereditary predisposition to breast cancer is considered an important etiological factor
for the disease. It is estimated that 10% to 25% of all cases of breast cancer are related
to hereditary predisposition. Early diagnosis of Hereditary Predisposition to Breast and
Ovarian Cancer Syndrome (HBOC), through the identification and characterization of
genetic mutations, is essential to establish a plan for surveillance, prevention and
personalized treatments for hereditary cancer. The objective of this work was to
characterize the clinical-epidemiological and genetic profile of patients with a clinical
diagnosis or family history of HBOC syndrome, who underwent counseling and genetic
testing in a specialized private service in Zona da Mata Mineira. This is a crosssectional study, with 275 patients who presented clinical criteria or family history for
HBOC between September 2017 and March 2022. Data collection was carried out
using an instrument designed to extract information from the electronic medical record.
A descriptive analysis was carried out to understand the distribution and prevalence of
the variables, followed by bivariate analysis. In the first phase, genetic testing was
defined as the dependent variable for all pollution investigated. In subsequent
analyses, which included only patients who underwent genetic testing, history of
cancer was considered as the dependent variable (personal history of cancer versus
only family history suggestive of HBOC Syndrome). The predictor variables were
sociodemographic, tumor profile and genetic tests. To verify existing associations, the
Chi-square, considering those with p ≤ 0.05 to be statistically significant. Among the
patients investigated, it was found that the proportion of patients with black skin color
(36.2%) and less education (26.0%) was significantly higher in patients who did not
undergo genetic testing compared to those who performed it, respectively 2.6% and
10.6%. No significant differences were found in relation to skin color, education and
region of residence, according to history of cancer. However, there were higher
percentages of patients living outside the reference municipality, both among those
with a personal history of cancer (51.9%) and among those with only a family history
of HBOC Syndrome (59.3%). In relation to genetic variables, a higher percentage of
family history of cancer in a first-degree relative (67.8%) was observed among patients
with only a family history suggestive of HBOC Syndrome, in relation to those with a
personal history of cancer (50 .8%) – although with only marginal significance (p=0.07).
Regarding the results of the genetic test, no significant difference was found depending
on the patients' cancer history. However, there is a tendency for patients with only a
family history suggestive of HBOC Syndrome to have a slightly higher proportion of
variants present (PP/P) compared to those with a personal history of cancer. The
findings of this study contribute to a more comprehensive understanding of HBOC
Syndrome and its clinical implications, highlighting the need for equitable medical care.
Emphasizes the continued need for research and education about breast cancer,
especially regarding hereditary predisposition. It highlights the importance of equity in
access to health services, regardless of race, level of education, social or financial
position, as well as the need for policies and interventions to combat inequalities and
achieve universal health care.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

